| Literature DB >> 20875742 |
Achintya K Bandyopadhyaya1, Brad D Manion, Ann Benz, Amanda Taylor, Nigam P Rath, Alex S Evers, Charles F Zorumski, Steven Mennerick, Douglas F Covey.
Abstract
Alphaxalone, a neuroactive steroid containing a 17β-acetyl group, has potent anesthetic activity in humans. This pharmacological activity is attributed to this steroid's enhancement of γ-amino butyric acid-mediated chloride currents at γ-amino butyric acid type A receptors. The conversion of alphaxalone into Δ(16)-alphaxalone produces an analogue that lacks anesthetic activity in humans and that has greatly diminished receptor actions. By contrast, the corresponding 17β-carbonitrile analogue of alphaxalone and the Δ(16)-17-carbonitrile analogue both have potent anesthetic and receptor actions. The differential effect of the Δ(16)-double bond on the actions of alphaxalone and the 17β-carbonitrile analogue is accounted for by a differential effect on the orientation of the 17-acetyl and 17-carbonitrile substituents.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20875742 PMCID: PMC2965472 DOI: 10.1016/j.bmcl.2010.09.008
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823